Company / Capital Returned to Shareholders per Share
West Pharmaceutical Services Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$2.70
FY2025
5-year range
$1.73 / $8.44
FY2021-FY2025
Trend
-68.0%
vs FY2024
Sector context
#41 of 108
Health Care
What the data says
At $2.70, West Pharmaceutical Services's capital returned to shareholders per share ranks #41 of 108 in the Health Care sector. Capital Returned to Shareholders per Share has fluctuated over the past 10 years, ranging from $0.40 in FY2016 to $8.44 in FY2024.
Based on SEC 10-K filings.
2.70 in FY2025 with a 5-year CAGR of +12.1%.
Declined from $6.68 to $2.70 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- +7.0%
- 5-Year CAGR
- +12.1%
- 10-Year CAGR
- -
Sector benchmark
-45.4% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share decreased 68.0% year-over-year.
- Ranks #41 out of 108 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2024.
- Lowest capital returned to shareholders per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.70 | -68.0% |
| FY2024 | $8.44 | +26.2% |
| FY2023 | $6.68 | +203.2% |
| FY2022 | $2.20 | +27.3% |
| FY2021 | $1.73 | +13.7% |
| FY2020 | $1.52 | -11.9% |
| FY2019 | $1.73 | +13.2% |
| FY2018 | $1.53 | -1.6% |
| FY2017 | $1.55 | +285.8% |
| FY2016 | $0.40 | +7.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026